by Pete Celano | Apr 15, 2026 | Blog
Lisa Norris is the Managing Director & Principal at Transplant Leadership Institute LLC, and a veteran Transplant Services Director. This is her superb book relating to the $11 billion in annual revenue mega-industry that is Liver (and other) transplants in the...
by Brandon Tudor | Apr 13, 2026 | Blog
Liver disease can turn into liver cancer through a gradual, multi-step process driven by chronic damage, inflammation, and cell mutation. Here’s the clearest way to understand it: 1. Chronic liver injury starts the process Common causes: Fatty liver disease (MASLD /...
by Pete Celano | Apr 10, 2026 | Blog
The JAMA Network Open article of 01/26/2026 titled “Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs” is revelatory–🧠 Study Overview Topic and link: Mobile telemedicine for treating chronic hepatitis C (HCV)...
by David Sires | Apr 9, 2026 | Blog
The article “8 takeaways about MASH, an increasingly common liver disease associated with obesity” from Managed Care Executive dated April 7, 2026, has a cogent analysis on MASLD/MASH. Summarized– 8 Key Takeaways About MASH (Fatty Liver Disease) MASH...
by Pete Celano | Apr 7, 2026 | Blog
Here we summarize “Association between metabolic dysfunction-associated steatotic liver disease and obstructive sleep apnea: a nationwide retrospective cohort study” from Scientific Reports (Nature Portfolio), March 2026. 🎯 Objective The study examined...
by Brandon Tudor | Apr 6, 2026 | Blog
There’s an important article titled “Par for the course? Comparative effectiveness of PPAR agonists in PBC” from April 2026 in Hepatology by Robert M. Wilechansky, and it’s summarized below– 🧠 Summary 1) Context: why this matters Primary...
